Success in alliances and acquisitions is rare. Top executives focus – what, where and when. Developing such focus can take decades of trial, and error. Your company can ill afford errors. They delay benefits and divert resources.

Value-Inflection Points (VIPs) capture and systematize the experts’ ability to focus on what matters. They increase value, accelerate success, optimize investment and develop leaders. VIPs are now foundational at several dozen major pharmaceutical and biotechnology companies, as well as industries from mining to software development.

BTD is launching a 6-part podcast series to help executives find the moments that matter. In this podcast, join David S. Thompson, Global Head of Alliance Management at BeiGene Pharmaceuticals and HBR author, Tim O’Connor, Group Exploration Officer at BHP, and Dr. Victoria Dalton, internationally renowned executive coach. Along with your host, BTD Partner Nick Palmer, these VIP experts help you to understand and capitalize on VIPs in your companies.

The episodes cover the fundamental concepts. They go on to discuss using VIPs with your alliances and integrations.

• Identify VIPs for your deals.
• Manage complex initiatives using VIPs.
• Incorporate VIPs in your company’s strategy, design and implementation.
• Build alliance and integration teams that maximize the impact of VIPs.

These are intellectual journeys, not presentations. Learn from the executives who first codified and now lead the VIP revolution! Join us for the learning. Join us for inspiration. Join us for some fun.

One in two people will develop some form of cancer in their lifetimes. Despite decades of work, one-sixth of worldwide deaths are due to cancer. High-stakes research underpinned by strong alliances are making possible new therapies, bringing new hope.

In this podcast, Julie Little (Associate Director of Strategic Alliances) and Steve Wedge (Chief Scientific Officer) of Cancer Research UK discuss their organisation’s major role de-risking oncology research. CRUK has catalysed collaborations including biotech startups and big pharmaceutical companies alike. The newly formed Cancer Research Horizons will supercharge that mission.

BTD’s Nick Palmer leads the discussion. Learn more. Give it a listen.

#podcast #startups #biotech #research #oncology #pharmaceutical #alliances

A senior project, programme and integration professional, Louise Cooper joined the BTD team several years ago and has supported some of our largest and most complex engagements with clients such as Spectris and Glatfelter. In this podcast, Louise explores the differences between integration and more general transformation programmes, and what she finds challenging and fulfilling in her integration, separation and restructuring work.

www.btd.consulting
CLICK HERE to follow us on LinkedIn